Palantir's growth is of extremely high quality, showcasing accelerating growth. Click here to read why I keep a Hold rating ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

A stock can still have huge value even after a substantial rise in price. To find out if this is true for this FTSE 100 bank, ...

Sun Country Airlines is not selling any shares and will not receive any proceeds from the offering.

An Evercore analyst expects an upbeat earnings report later this month and runs down why DeepSeek fears seem overdone.

The Bombay High Court has dismissed the company's plea in a trademark dispute over the use of the Mansion House brand ...

Planning to start investing in 2025? This writer highlights two very different stocks that might be worth considering for a ...

No action is required by existing shareholders with respect to the name and ticker symbol change. The Committee on Uniform Securities Identification Procedures (CUSIP) also confirmed the CUSIP number ...

BofA Securities analyst Jason Gerberry increased the price target for Axsome Therapeutics (NASDAQ:AXSM) shares to $167 from the previous $143, while reiterating a Buy rating on the stock. This aligns ...

Still, you might imagine that claim would upset shareholders of Globalstar and AST SpaceMobile, which are also planning to ...

Have a consensus Buy rating: All of the stocks must have an average broker recommendation of 2.5 or less within S&P Global ...

Tech expert Kurt “CyberGuy" Knutsson says hackers are using Microsoft Teams for phishing, vishing and quishing via social ...